<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="hbaolong@vip.qq.com" />
  <title>癌症传EN:A City of Strings</title>
  <style>
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      background-color: #1a1a1a;
      border: none;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">癌症传EN:A City of Strings</h1>
<p class="author">hbaolong@vip.qq.com</p>
</header>
<center>
<a href="/3place/azzen">返回首页</a> <a
href="/3place/azzen/mingju.html">本书名句</a> <a
href="/3place/azzen/memo.html">本书注解</a> <a
href="/3place/azzen/index_rich.html">丰富目录</a> <a
href="/3place/azzen/index_readcal.html">同读日历</a> <a
href="/3place/azzen/index_timeline.html">时间线</a> <a
href="/3place/azzen/index_books.html">引用书籍</a> <a
href="/3place/azzen/index_words.html">使用字频</a>
<div id="wx_pic" style="margin:0 auto;display:none;">
<img src='/img/logo.png'/>
</div>
</center>
<h4 id="a-city-of-strings">A City of Strings</h4>
<p>412 In Ersilia, to establish the relationships: Italo Calvino,
Invisible Cities (Boston: Houghton Mifflin Harcourt, 1978), 76.</p>
<p>412 In his book Invisible Cities: Ibid.</p>
<p>413 In the summer of 1984: Robert Bazell, Her-2: The Making of
Herceptin, a Revolutionary Treatment for Breast Cancer (New York: Random
House, 1998).</p>
<p>414 In 1982, Genentech unveiled the first: “A New Insulin Given
Approval for Use in U.S.,” New York Times, October 30, 1982.</p>
<p>414 in 1984, it produced a clotting factor: “Genentech Corporate
Chronology,” http://www
.gene.com/gene/about/corporate/history/timeline.html (accessed January
30, 2010).</p>
<p>414 in 1985, it created a recombinant version: Ibid.</p>
<p>414 It was under the aegis: L. Coussens et al., “3 Groups Discovered
the Neu Homolog (Her-2, Also Called Erb-b2),” Science 230 (1985):
1132–39. Also see T. Yamamoto et al., Nature 319 (1986): 230–34, and C.
King et al., Science 229 (1985): 974–76.</p>
<p>415 In the summer of 1986: Bazell, Her-2, and Dennis Slamon,
interview with author, April 2010.</p>
<p>415 Dennis Slamon, a UCLA oncologist: Ibid.</p>
<p>415 a “velvet jackhammer”: Eli Dansky, “Dennis Slamon: From New
Castle to New Science,” SU2C Mag, http://www.standup2cancer.org/node/194
(accessed January 24, 2010).</p>
<p>415 “a murderous resolve”: Ibid.</p>
<p>415 In Chicago, Slamon had performed a series: See, for example, I.
S. Chen et al., “The x Gene Is Essential for HTLV Replication,” Science
229, no. 4708 (1985): 54–58; W. Wachsman et al., “HTLV x Gene Mutants
Exhibit Novel Transcription Regulatory Phenotypes,” Science 235, no.
4789 (1987): 647–77; C. T. Fang et al., “Detection of Antibodies to
Human T-Lymphotropic Virus Type 1 (HTLV-1),” Transfusion 28, no. 2
(1988): 179–83.</p>
<p>415 If Ullrich sent him the DNA probes: Details of the Ullrich and
Slamon collaboration are outlined in Bazell, Her-2, and from Slamon,
interview with author.</p>
<p>416 In a few months: D. Slamon et al., “Human Breast Cancer:
Correlation of Relapse and Survival with Amplification of the Her-2/Neu
Oncogene,” Science 235 (1987): 177–82.</p>
<p>417 In the mid-1970s, two immunologists at Cambridge University: See
Nobel Lectures, Physiology or Medicine, 1981–1990, ed. Jan Lindsten
(Singapore: World Scientific Publishing, 1993).</p>
<p>418 “allergic to cancer”: Merrill Goozner, The 00 Million Pill: The
Truth Behind the Cost of New Drugs (Berkeley: University of California
Press, 2004), 195.</p>
<p>418 Drained and dejected: Ibid.</p>
<p>418 “Nobody gave a shit”: Bazell, Her-2, 49.</p>
<p>419 “When I was finished with all that”: Ibid. Also Barbara
Bradfield, interview with author, July 2008.</p>
<p>419 But there was more river to ford: Ibid.</p>
<p>420 “His tone changed,” she recalled: Ibid.</p>
<p>420 “I was at the end of my road”: Ibid</p>
<p>420 “Survivors look back and see omens”: Joan Didion, The Year of
Magical Thinking (New York: Vintage, 2006), 152.</p>
<p>420 On a warm August morning in 1992: Bradfield, interview with
author. Details of the trial and the treatment are from Bradfield’s
interview, from Bazell’s Her-2, and from Slamon, interview with author,
April 2010.</p>
<h6 id="阅读日期-2026年02月08日-2026年02月08日-共-1-天">阅读日期：
2026年02月08日-2026年02月08日 共： 1 天</h6>
<script src="https://giscus.app/client.js"
        data-repo="hbaolong/hbaolong.github.io"
        data-repo-id="R_kgDOLetDQg"
        data-category="General"
        data-category-id="DIC_kwDOLetDQs4CfLEl"
        data-mapping="url"
        data-strict="0"
        data-reactions-enabled="1"
        data-emit-metadata="1"
        data-input-position="top"
        data-theme="preferred_color_scheme"
        data-lang="zh-CN"
        crossorigin="anonymous"
        async>
</script>
</body>
</html>
